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2         ABSTRACT
Fucosylation is a common modification and its site in glycans refers to different normal and 
pathological processes. Despite intensive research, there is still a lack of methods to discriminate 
unambiguously the fucose position in one-step. In this work, we propose utility of phenylhydrazine 
(PHN) labeling for structural studies of fucosylated N-glycans by tandem MALDI mass spectrometry 
(MS) in the positive ion mode. PHN-tag influences the production of specific ion types and MS/MS 
fragmentation pattern provides useful structural information. All types of core fucosylated N-glycans 
have produced two abundant ions consistent with B- and C-glycosidic cleavages corresponding to the 
loss of FucGlcNAcPHN residue with mass 457 and 441 Da from the parent ions. These types of 
fragment ions in N-glycans without a core fucose were associated with the loss of GlcNAcPHN unit 
(311 and 295 Da) and fucose cleavage followed loss of the chitobiose residue. Since diagnostic useful 
cleavages produce peaks with significant intensities, this approach is also beneficial for rapid 
recognition of antenna from core fucosylation in glycans detected with low abundances. Moreover, 
in multifucosylated glycans this type of labeling allows to distinguish how many fucose residues are 
on the specific antenna and provides additional information on the topology of N-glycans such as 
type of antennarity or identification of bisecting moiety. The practical applicability of the approach 
is demonstrated on the analysis of multifucosylated N-glycans detected with lower abundances in 
lung cancer samples. 
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N-linked protein glycosylation is a venerable posttranslational modification and one of the pervasive 
regulatory mechanisms participated in multiply biological processes.1 Among distinctive features of 
N-glycans is their structural variability.2 Fucosylation is one of the structural features of glycosylated 
proteins.3 The position of the fucose residue/s in the glycans results on expression of fucosylation-
related enzymes, of which the up or downregulation depends on different normal and pathological 
processes.4-10 
Methods for determination of this intriguing monosaccharide residue are based on using the 
high-performance liquid chromatography or MS after repeated digestions with specific enzymes.11–
13 MS is one the most sensitive, rapid and routinely used technique for analysis of glycoconjugates. 
However, it is not very useful for direct assignment of a fucose position in native glycans because of 
its lability and extensive migration during tandem MS experiments. Derivatization techniques 
minimize the fucose loss,11,14,15 but still lead to ambiguity and are laborious for routine application.16   
To simplify and apply only MS strategy for validation of core fucosylastion, Nwosu et al. proposed 
an alternative method based on detection of N-glycans labeled with procainamide.16 The core 
fucosylated glycans were confirmed by diagnostic peak detected at m/z 587 corresponding to 
composition GlcNAcFucProcainamideH+. Whereas its absence in the spectra indicated the presence 
of fucose on an antenna.16 The researcher presented useful application of this method towards 
veriﬁcation of core fucosylation in a therapeutic protein IgG1. Mancera-Arteua et al. proposed μZIC-
HILIC-MS/MS method in negative ion mode .17 The absence of the Y1 ion at m/z 297 in the tandem 
mass spectra was associated with core fucosylation. Whereas this peak was detected in the spectra of 
the non-fucosylated glycans. The other combined ions such as 2,4A5/Y5 suggested that the fucose was 
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4not located on any antenna. Lastly, Harvey & Struwe demonstrated the ability of negative  collision-
induced dissociation combined with ion mobility for more detailed characterization of  fucosylated 
N-glycans including tri-antennary ones.18 The spectra provided useful information about number and 
position of fucose residues on specific antenna. 
   We previously reported MS  analyses of N-glycans obtained from different sample sources by 
employing non-reducing type of derivatization with PHN on reducing termini of glycans.19,20  Besides 
simplicity of this labeling technique, we showed on a number of different N-glycans that under 
tandem MS conditions these derivatives fragmented in a predictable manner. They preserved the 
advantages of important diagnostic ions observed on native glycans,21 but avoiding ambiguity in 
structural assignments.19 Here we applied this approach to demonstrate its capability for an efficient 
discrimination of core from antenna fucosylation. Thanks to the presence of diagnostic ions with 
significant intensities, this approach is applicable for a recognition of the fucose residue also in low 
abundant N-glycans. The usefulness of this rapid method is demonstrated on the analysis of larger 
than three antennary N-glycans carrying multiply fucose residues.  
EXPERIMENTAL SECTION
Materials. 
All chemicals, solvents, enzymes and monoclonal antibody (mab) Rituximab were purchased from 
Sigma. Lung cancer cells (HTB-171) were used from previous study22  and  lung cancer tissue was 
obtained through bronchoscopy following the protocol approved by the regional Ethics Committee 
of University Hospital in Brno. 
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5Release of N-glycans. 
N-glycans release from IgG1. Rituximab (50 µg)  dissolved in 5mM of ammonium bicarbonate (AB) 
solution (100 µL) was incubated with PNGase F at 37oC for 1-3h. After that 2 µL was taken from a 
digest, spotted on the MALDI target and after derivatization analyzed as described in the MS section.
N-glycans release from cancer samples. Prior to the PNGase F deglycosylation, cancer cells or biopsy 
samples underwent extraction as described previously.22 Briefly, 300 µL of mixture consisting from 
chloroform-methanol-water (CMW in ratio 8:4:1) was added to the each sample and sonicated for 5 
min at room temperature. After short centrifugation, the organic solvent was pipetted out and crude 
sediment was vacuum evaporated. N-glycans were released from samples with PNGase F in 5 mM 
AB solution (100 µL) at 37oC for 3h; and alternatively followed the incubation (2h) with 
neuraminidase (Clostridium perfringens). After incubation and brief centrifugation, the supernatants 
were fractionated on nonporous graphitized carbon cartridges. The glycan fractions were dried under 
vacuum.
PHN derivatization and MS analysis. 
Purified glycans were reconstituted in deionized water (20 μL) and subjected to on-target 
derivatization.22 Matrix was prepared by mixing of 2-aza-2-thiothymine and phenylhydrazine 
hydrochloride (ATT/PHN.HCl, 2:1) with the final concentration 2% in ACN/deionized water (1:1).  
0.8 μL of the matrix solution was spotted on the surface of the AnchorChip target and immediately 
followed addition of glycan solution (~1.5 μL). To the still wet spot, 0.6 μL of PHN reagent 
(PHN:ACN:Water in ratio 1:0.5:4) was added and left air dry (5-10 min). MALDI-TOF/TOF-MS 
analysis was carried on UltrafleXtremeTM mass spectrometer furnished with a Smartbeam-II laser and 
LIFT technology (Bruker, Germany). The instrument was used in the reflectron positive mode, 
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6calibrated externally using mixture of peptides and then internally using known glycans. Individual 
parent ions were selected for LIFT experiments. MS/MS spectra were evaluated manually using 
fragmentation rules described earlier.19,20 For drawing glycan structures, the symbolic nomenclature 
recommended by the Consortium for Functional Glycomics was applied 
(http://www.functionalglycomics.org/). Fragment ions in tandem mass spectra were assigned using 
the Domon & Costello nomenclature.23
RESULTS AND DISCUSSION
For this study, N-glycans were obtained after enzymatic digestion from the IgG1,  more complex 
fucosylated N-glycans characterized using exoglycosidase cleavages were from previous work22 and 
from cancerous lung tissue obtained during bronchoscopy. In case of IgG1, N-glycans were analyzed 
immediately after digestion without applying any purification step.
Core fucosylated N-glycans. Therapeutic IgG1 (Rituximab) was chosen here as standard since 
this glycoprotein has simple glycan profile of known structural compositions and majority of them 
are core fucosylated.  As reported previously derivatization with PHN is a simple reaction and in case 
of analysis of not very complex samples, it can provide benefit in immediate analysis of N-glycans 
without using any purification step.20  We already illustrated this advantage on the analysis of 
therapeutic Herceptin.24 Similarly, here, after 2 hours of digestion, the main glycan profile of IgG1 
corresponded to that when applying HILIC purification and analysis using ultra performance liquid 
chromatography coupled with MS.16  The main glycans with PHN-tag were observed at m/z 1575.5 
(GlcNAc2Man3GlcNAc2Fuc), 1737.6 (Gal1GlcNAc2Man3GlcNAc2Fuc) and 1899.7 
(Gal2GlcNAc2Man3GlcNAc2Fuc). Under tandem MS, these peaks produced characteristic ions 
confirming only core type of fucosylation. In the Figure 1 are shown tandem mass spectra recorded 
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7for biantennary complex N-glycans. When no fucose is on the chitobiose core, the abundant fragment 
ions associated with B- and C-glycosidic cleavages at highest m/z values are associated with the loss 
of  311 Da (B-ion) and 295 Da (C-ion) corresponding to the loss of GlcNAcPHN residue from the 
parent ions (Figure 1A). However, when glycan is core fucosylated, the same types of cleavages are 
associated with the loss of FucGlcNAcPHN  producing abundant B,C-fragments with the typical  loss 
of 457 Da (B-ion) and 441 Da  (C-ion) from the precursors ions (Figure 1B). In this spectrum, no 
additional fragments corresponding to the loss of 311 and 295 Da (GlcNAcPHN residue) from the 
precursor ions were detected. Thus, confirming glycan with fucose attached only to the core region. 
In both MS/MS spectra shown in the Figure 1A and B, after the first glycosidic cleavages follows the 
abundant loss of a second GlcNAc residue from the chitobiose core. The absence of the chitobiose 
core mostly produces peak with higher intensity for C ion over B ions. The loss of monosaccharide 
residues from the antenna attached to the 3-position of the branching mannose produced abundant 
B4/Y3α ion (D-ion) at m/z 712 accompanied with characteristic loss of water (m/z 694) as described 
previously.19–21 When analyzing the same glycan in the native form, abundant ions corresponded to 
the loss of monosaccharide residues from both reducing and non-reducing ends of glycan (Figure S1). 
At least two peaks with high intensities (m/z 1663 and 1298) were associated with the loss of fucose 
residue. These and other competing losses of monosaccharide residues did not provide opportunity 
to assign a core fucosylation with no ambiguity as it was possible for this glycan when labeled with 
PHN (Figure 1B).  The similar pattern was observed in the spectra recorded for the precursor ions at 
m/z 1575, 1737 (Figure S2). In case of procainamide derivatized glycans, core fucosylation was 
confirmed based on the presence of the peak at m/z 587, frequently detected with low intensity.16 
Therefore, it was not possible to confirm this fragment in case of low abundant glycans as the authors 
indicated in their work. Whereas, when applying PHN labelling, the key cleavages produce peaks 
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8with significant intensities. Thus, it provides opportunity to identify unambiguously the core fucose 
even in case of low abundant glycans detected at m/z 1372 and 1534 in IgG1 (Figure S3).
Core versus antenna fucosylation. The simple example how to validate assignment of fucose on 
the reducing termini discussed above and its discrimination from antenna fucosylation, is illustrated 
on a comparison of tandem MS spectra shown in Figure 1B and 1C.  Figure 1C represents spectrum 
recorded from cancerous lung tissue for the same precursor ions as detected in IgG1 (Figure 1B). The 
peak at m/z 1899 analyzed in the biopsy provided fragmentation pattern corresponding to the core 
fucosylated glycan (Structure 1) as observed in IgG1 (Figure 1B). An additional fragments identified 
at m/z 1598 (B5 ion) and 1604 (C5 ion) were associated with the loss of non-fucosylated GlcNAcPHN 
residue (311 or 295 Da) and then the total loss of chitobiose core at m/z 1385 and 1401 (B4 and C4 
ions). These fragments supported the presence of second isomer with no core fucose, however having 
this subunit on one of the antennae (Figure 1C; Structure 2). The relative summed intensities of B5 
and C5 ions associated with the loss of FucGlcNAcPHN residue compared with the summation of the 
intensities of the same ion types, however associated with the loss of GlcNAcPHN from the parent 
ion, indicates that the core and antenna fucosylated glycans in the mixture are approximately in the 
ratio of 3:1 (Figure 1C).  
Applicability of the method for identification of more fucosylated N-glycans. MS/MS patterns of 
PHN labeled glycans is very similar in case of the biantennaery core fucosylated glycans with 
bisecting moiety and carrying additional fucose residues on the arms (Figure 2). In the spectra of both 
glycans, any fragment ions corresponding to the reducing termini without fucose (the loss of 311 and 
295 Da) was not observed.  N-glycan with composition Gal2GlcNAc3Man3GlcNAc2Fuc detected at 
m/z 2103, in its MS/MS spectrum after the loss of FucGlcNAcPHN  residue  (m/z 1645 and 1661) 
produced other dominant ion consistent with C-type of glycosidic cleavage accompanied with smaller 
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9peak at m/z 1442 (B4 ion), associated with the loss of chitobiose core (Figure 2A).  The loss of 
monosaccharide residues from the 3-antenna was associated with a higher peak at m/z 915 (B4/Y3α 
ion). The presence of a bisecting moiety was recognized based on the significant loss of 221 Da from 
B4/Y3α fragment ions,19,20 the same phenomenon as observed in MS/MS spectra of native glycans.21 
The similar principle of fragmentation we observed in the spectrum recorded for the other glycan 
with additional two fucoses - Fuc2Gal2GlcNAc3Man3GlcNAc2Fuc, detected at m/z 2395 in cancer 
cells (Figure 2B). The fragments at m/z 1588 and 1604 were associated with the loss of fucose (146 
Da) from B4 or C4 ions. The abundant fragment at m/z 1061 (B4/Y3α ion) was consistent with 
composition Fuc1Gal1GlcNAc2Man2 indicating third fucose residue linked on the 6-antenna.  
The practical applicability is next presented on the analysis of more antennary multifucosylated 
oligosaccharides shown in Figure 3. Although both glycans were detected with low abundances, their 
spectra exhibited characteristic cleavages and still sufficient data to confirm presence of dominant 
core fucosylated structures (the loss of 311 and 295 from both precursor ions was not observed). As 
reported previously, fucose is very labile and there are difficulties to confirm this residue on the 
antenna versus core by using only tandem mass technology in the positive mode.18 However, our 
results indicate that the PHN-tag on the reducing end has positive impact on fragmentation and can 
be used to discriminate reliably core from antennae fucosylation. Moreover, characteristic ions make 
possible to predict a position of this residue on the antenna type. For example, the tetra-antennary 
glycan with precursor at m/z 2922 after the total loss of fucosylated chitobiose core (B4 or C4 ions) 
and monosaccharide residues from the 3-antenna at m/z 1368 (B4/Y3β ion) indicated major isomeric 
structure with extra two fucose residues only on the 6-antenna (Figure 3A).  A similar MS/MS pattern 
was observed for the core fucosylated glycans detected at m/z 3579, carrying additional 
FucGalGlcNAc residue on the 6-arm and fifth fucose attached to one of the monosaccharide residues 
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on the 3-antenna (Figure 3B). The significant B4/Y3α peak (D-ion) appeared at m/z 1880 and was in 
a favor of main isomer with additional one fucose on the 3-antennae and three fucoses on the 6-
antenna. Although, the purpose of this study was not exact assignment on which monosaccharide 
residue of the antenna is fucose linked, very low abundant peaks observed at m/z 899, 1045, 1248 and 
2392 could indicate the linkage of fucose to GlcNAc residues. 
Core 1,3- versus core 1,6-linked fucose. Tandem MS of different types of core fucosylated glycans 
from mammals (1,6-linkage) with no fucose on the antenna,  did not show the presence of any 
fragment corresponding solely to the loss of fucose (146 Da) from the parent ions (e.g. Figure 1B, 
2A, Figures S2 and 3). Instead, this loss was observed together with A-type cross-ring cleavage from 
the reducing end (0,1Ax-146).  On the other side, antenna fucosylated glycans, produced a peak 
associated with the loss of fucose residue from the parent ions.  The same loss was observed in the 
analysis of  N-glycans obtained from plant sources when fucose was 1,3-linked to the core region.25  
These differences are illustrated on the spectra recorded for simple N-glycans of the same 
compositions when analyzed in lung tissue with 1,6-linked core fucose (Figure S4A) and in patatins 
with 1,3-linked core fucose (Figure  S4B). In the second spectrum, the fragment at m/z 861 is 
associated with a loss of 146 Da. However, there was not detected any ion corresponding to the loss 
of 311 and 295 Da (GlcNAcPHN) from the precursor ion in this or other analyzed plant glycans. This 
information indicates additional potential of this approach for rapid discrimination of 1,6- from 1,3-
linked core fucose. 
CONCLUSION
In this study, we demonstrate the capability of PHN-labeling for rapid recognition of fucosylation in 
N-glycans using MALDI-MS/MS analysis. Besides already proved simplicity of this procedure, we 
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show that this labeling provides fragmentation patterns allowing for discrimination of core versus 
antennae fucosylationin in one-step. Since the diagnostic useful peaks are produced with significant 
intensities, the method is efficient for very low abundant glycans as well. Additionally, the processing 
time starting with digestion and ending with MS analysis including manual data interpretation does 
not exceed 4 hours in case of simple samples such as biopharmaceutical relevant antibodies. The 
results also point to the utility of PHN-tag for differentiation of the core fucose with 1,6-linkage from 
that linked to 1,3-core region.  Moreover, as evidenced from analysis of different fucosylated glycans 
from bi to five antennary structures, tandem mass spectra provide direct information on the 
antennarity type and presence of bisecting GlcNAc residue with additional possibility to predict how 
many fucoses are on a specific antenna. 
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Figure 1. MALDI-TOF/TOF tandem mass spectra recorded for the complex biantennary 
N-glycans with precursor ions at: (A) m/z 1753.6 identified in lung tissue; (B) m/z 1899.7 
detected in IgG1; and (C) m/z 1899.7 detected in biopsy of patient with lung metastases. 
Key symbols:         Fuc;         GlcNAc;        Man;         Gal;
  
Figure 2. MALDI-TOF/TOF tandem mass spectra of biantennary fucosylated N-glycans 
with bisecting GlcNAc residue recorded from lung cancer cells for the precursor ions with
m/z: A) 2102.8; and  B) 2394.9. Fragmentations schemes indicate dominant isomeric structures 
Figure 3. MALDI-TOF/TOF tandem mass spectra recorded for fucosylated more antennary
N-glycans for precursor ions with m/z: A) 2922.1 (from lung cancer cells); and B) m/z 3579.3
detected in biopsy of a patient with lung metastases. Dominant structure for each glycan is 
suggested based on characteristic major losses of monosaccharides residues. 
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